Jasik M, Zdrojewicz Z, Stawicki S
Katedry i Kliniki Gastroenterologii i Chorób Przemiany Materii Akademii Medycznej w Warszawie.
Wiad Lek. 1999;52(3-4):202-10.
The aim of this presentation is evaluation of the renin-angiotensin-aldosterone system (RAA) in selected diseases of endocrine glands. In patients with acromegaly, Conn's syndrome, hyperparathyroidism, hyperthyroidism, hypothyroidism, phaeochromocytoma and Cushing's disease is possible to formulate the temporarily conclusions according to subsidiary meaning of angiotensin converting enzyme inhibitors (ACE I) in these endocrinopathies. Whereas the ACE I play an important role in the treatment of nephropathy and hypertension in diabetes mellitus.
本报告的目的是评估内分泌腺特定疾病中的肾素-血管紧张素-醛固酮系统(RAA)。对于肢端肥大症、原发性醛固酮增多症、甲状旁腺功能亢进、甲状腺功能亢进、甲状腺功能减退、嗜铬细胞瘤和库欣病患者,根据血管紧张素转换酶抑制剂(ACE I)在这些内分泌疾病中的辅助作用,可以得出临时结论。而ACE I在糖尿病肾病和高血压的治疗中发挥着重要作用。